Gregory Downey - Aug 29, 2022 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Role
Chief Financial Officer
Signature
/Gregory Downey/
Stock symbol
LEXX
Transactions as of
Aug 29, 2022
Transactions value $
$0
Form type
4
Date filed
8/29/2022, 05:08 PM
Previous filing
Sep 2, 2021
Next filing
Oct 18, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LEXX common shares 1.83K Aug 29, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LEXX Stock Options Award $0 +11K +31.43% $0.00 46K Aug 29, 2022 Common Shares 11K $2.91 Direct
holding LEXX Stock Options 4K Aug 29, 2022 Common Shares 4K $5.04 Direct
holding LEXX Stock Options 8K Aug 29, 2022 Common Shares 4K $5.04 Direct
holding LEXX Stock Options 12K Aug 29, 2022 Common Shares 4K $5.04 Direct
holding LEXX Stock Options 17K Aug 29, 2022 Common Shares 5K $5.31 Direct
holding LEXX Stock Options 25K Aug 29, 2022 Common Shares 8K $7.08 Direct
holding LEXX Stock Options 35K Aug 29, 2022 Common Shares 10K $6.23 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.